Finance

Lists
Q3 2026 earnings • released • Revenue miss -2,03%
See results
ALM:BME
Almirall SA
10,72 €
-0,56%
(-0,060) 1D
13 ნოე, 17:29:52 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ALM...
Open
10,70 €
High
10,84 €
Low
10,62 €
Mkt. cap
2,33 მლრდ.
Avg. vol.
141,50 ათ.
Volume
52,84 ათ.
Dividend
1,74%
Quarterly dividend
0,05 €
Ex-dividend date
30 მაი. 2017
P/E ratio
39,00
52-wk high
13,98 €
52-wk low
9,81 €
EPS
0,27 €
Shares outstanding
217,78 მლნ.
No. of employees
2 ათ.
Open
10,70 €
High
10,84 €
Low
10,62 €
Mkt. cap
2,33 მლრდ.
Avg. vol.
141,50 ათ.
Volume
52,84 ათ.
Dividend
1,74%
Quarterly dividend
0,05 €
Ex-dividend date
30 მაი. 2017
P/E ratio
39,00
52-wk high
13,98 €
52-wk low
9,81 €
EPS
0,27 €
Shares outstanding
217,78 მლნ.
No. of employees
2 ათ.
News stories
From web sources and news partners
Profile
Almirall, S.A. is a Spanish pharmaceutical company dedicated to medical dermatology, with headquarters in Barcelona, founded in 1944. In 2023, the company generated total revenues of €898.8 million and was the leading European company in medical dermatology. With approximately 1,904 employees, it has a direct presence in 20 countries through its 15 subsidiaries in Europe and the USA. Wikipedia
About Almirall SA
CEOGianfranco Nazzi | კარლოს გალიარდო პიკე
Employees2,1 ათ.
Founded1944
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitealmirall.com
Last report
9 ნოე. 2026
Fiscal period
Q3 2026
- / 0,08 €
Revenue / Est. (EUR)
287,98 მლნ. / 293,94 მლნ.
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
დეკ. 2025
მარ. 2026
ივნ. 2026
სექ. 2026
Revenue
288,93 მლნ.
292,40 მლნ.
313,22 მლნ.
287,98 მლნ.
Cost of goods sold
-27,67 მლნ.
104,30 მლნ.
31,26 მლნ.
177,34 მლნ.
Cost of revenue
-27,67 მლნ.
104,30 მლნ.
31,26 მლნ.
177,34 მლნ.
Research and development expenses
-102,40 მლნ.
34,80 მლნ.
-34,80 მლნ.
107,10 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-102,92 მლნ.
121,60 მლნ.
14,88 მლნ.
229,22 მლნ.
Operating expense
310,92 მლნ.
158,10 მლნ.
240,19 მლნ.
74,61 მლნ.
Total operating expenses
283,25 მლნ.
262,40 მლნ.
271,44 მლნ.
251,96 მლნ.
Operating income
5,69 მლნ.
30,00 მლნ.
41,78 მლნ.
36,02 მლნ.
Other non operating income
3,36 მლნ.
-1,70 მლნ.
-2,27 მლნ.
3,97 მლნ.
EBT including unusual items
9,35 მლნ.
23,40 მლნ.
37,45 მლნ.
21,05 მლნ.
EBT excluding unusual items
5,78 მლნ.
24,50 მლნ.
36,46 მლნ.
30,64 მლნ.
Income tax expense
2,29 მლნ.
8,10 მლნ.
13,20 მლნ.
7,30 მლნ.
Effective tax rate
24,54%
34,62%
35,24%
34,70%
Other operating expenses
365,05 მლნ.
1,70 მლნ.
184,83 მლნ.
-186,43 მლნ.
Net income
7,05 მლნ.
15,30 მლნ.
24,25 მლნ.
13,75 მლნ.
Net profit margin
2,44%
5,23%
7,74%
4,77%
Earnings per share
-
-
-
-
Interest and investment income
1,35 მლნ.
1,00 მლნ.
1,54 მლნ.
-
Interest expense
-5,05 მლნ.
-4,50 მლნ.
-4,62 მლნ.
-9,22 მლნ.
Net interest expenses
-3,70 მლნ.
-3,50 მლნ.
-3,08 მლნ.
-9,22 მლნ.
Depreciation and amortization charges
151,18 მლნ.
-
75,28 მლნ.
-75,28 მლნ.
EBITDA
23,70 მლნ.
67,50 მლნ.
69,12 მლნ.
85,08 მლნ.
Gain or loss from assets sale
199,00 ათ.
-
114,00 ათ.
-114,00 ათ.
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები